These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21803114)

  • 1. Zonisamide produces weight loss in psychotropic drug-treated psychiatric outpatients.
    Lim J; Ko YH; Joe SH; Han C; Lee MS; Yang J
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1918-21. PubMed ID: 21803114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial.
    McElroy SL; Suppes T; Keck PE; Black D; Frye MA; Altshuler LL; Nolen WA; Kupka RW; Leverich GS; Walden J; Grunze H; Post RM
    J Clin Psychiatry; 2005 May; 66(5):617-24. PubMed ID: 15889949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of add-on topiramate therapy in psychiatric patients with weight gain.
    Cates ME; Feldman JM; Boggs AA; Woolley TW; Whaley NP
    Ann Pharmacother; 2008 Apr; 42(4):505-10. PubMed ID: 18364406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.
    McElroy SL; Kotwal R; Hudson JI; Nelson EB; Keck PE
    J Clin Psychiatry; 2004 Jan; 65(1):50-6. PubMed ID: 14744168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive zonisamide for treatment refractory anxiety.
    Kinrys G; Vasconcelos e Sa D; Nery F
    Int J Clin Pract; 2007 Jun; 61(6):1050-3. PubMed ID: 17504366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: a pilot study.
    Wang PW; Yang YS; Chandler RA; Nowakowska C; Alarcon AM; Culver J; Ketter TA
    J Psychiatr Res; 2008 May; 42(6):451-7. PubMed ID: 17628595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute treatment of bipolar depression with adjunctive zonisamide: a retrospective chart review.
    Baldassano CF; Ghaemi SN; Chang A; Lyman A; Lipari M
    Bipolar Disord; 2004 Oct; 6(5):432-4. PubMed ID: 15383137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zonisamide-induced weight loss in schizophrenia: case series.
    Yang J; Lee MS; Joe SH; Jung IK; Kim SH
    Clin Neuropharmacol; 2010; 33(2):104-6. PubMed ID: 19935403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is adjunctive open-label zonisamide effective for bipolar disorder?
    Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
    J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric adverse effects of zonisamide in patients with epilepsy and mental disorder comorbidities.
    Cavanna AE; Seri S
    Epilepsy Behav; 2013 Nov; 29(2):281-4. PubMed ID: 24070880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients.
    Wang PW; Hill SJ; Childers ME; Chandler RA; Rasgon NL; Ketter TA
    J Psychiatr Res; 2011 Aug; 45(8):1128-32. PubMed ID: 21371718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum leptin level is associated with zonisamide-induced weight loss in overweight female epilepsy patients.
    Kim DW; Yoo MW; Park KS
    Epilepsy Behav; 2012 Apr; 23(4):497-9. PubMed ID: 22440324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.
    McElroy SL; Kotwal R; Guerdjikova AI; Welge JA; Nelson EB; Lake KA; D'Alessio DA; Keck PE; Hudson JI
    J Clin Psychiatry; 2006 Dec; 67(12):1897-906. PubMed ID: 17194267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term topiramate treatment of psychotropic drug-induced weight gain: a retrospective chart review.
    Khazaal Y; Chatton A; Rusca M; Preisig M; Zullino D
    Gen Hosp Psychiatry; 2007; 29(5):446-9. PubMed ID: 17888813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide.
    Tosches WA; Tisdell J
    Epilepsy Behav; 2006 May; 8(3):522-6. PubMed ID: 16542880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy.
    Wellmer J; Wellmer S; Bauer J
    Acta Neurol Scand; 2009 Apr; 119(4):233-8. PubMed ID: 19053955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonisamide in the treatment of bulimia nervosa: an open-label, pilot, prospective study.
    Guerdjikova AI; Blom TJ; Martens BE; Keck PE; McElroy SL
    Int J Eat Disord; 2013 Nov; 46(7):747-50. PubMed ID: 23893331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
    Koga M
    Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.